Results 181 to 190 of about 119,702 (338)

Editorial: Exercise and neuroplasticity in Parkinson disease. [PDF]

Front Neurol
Hirsch MA, Dalgas U, van Wegen EEH.
europepmc   +1 more source

Parkinson Disease [PDF]

Mayo Clinic Proceedings, 2016
Rachael A, Vaubel, Aditya, Raghunathan, Lori A, Erickson   +2 more
openaire   +2 more sources

Surgical and non-surgical intervention for speech rehabilitation in Parkinson disease

, 2000
Heru Hendarto, Steven G. Gray
openalex   +2 more sources

A Controlled Trial of Rasagiline in Early Parkinson Disease [PDF]

, 2002

openalex   +1 more source

Inhibition of Ferroptosis Delays Aging and Extends Healthspan Across Multiple Species

Advanced Science, EarlyView.
This study identifies ferroptosis as a key driver of cellular senescence, with its inhibition delaying aging and extending healthspan across species. During senescence, ferroptosis worsens, increasing oxidative stress and lipid peroxidation, which accelerate aging.
Hai‐Jun Fu, Xing‐Yue Zhou, Da‐Lian Qin, Qan Qiao, Qiao‐Zhi Wang, Shi‐Ying Li, Yun‐Fei Zhu, Ya‐Ping Li, Jiang‐Min Zhou, Hui Cai, Fei‐Hong Huang, Lu Yu, Long Wang, An‐Guo Wu, Jian‐Ming Wu, Xiao‐Gang Zhou   +15 more
wiley   +1 more source

3‐[3‐(Phenalkylamino)cyclohexyl]phenols: Synthesis, biological activity, and in silico investigation of a naltrexone‐derived novel class of MOR‐antagonists

Archiv der Pharmazie, Volume 356, Issue 1, January 2023., 2023
Based on a simplified version of the morphinan scaffold, 3‐[3‐(phenalkylamino)cyclohexyl]phenol analogues were designed, synthesized and evaluated for their µ‐opioid receptor (MOR) antagonist activity in vitro and in silico. Docking studies indicate a peculiar combination of C‐1 stereochemistry and N‐substitutions as feasibly essential for MOR‐ligand ...
Graziella Tocco, Antonio Laus, Maksims Vanejevs, Anastasija Ture, Rafaela Mostallino, Nicholas Pintori, Maria Antonietta De Luca, M. Paola Castelli, Gaetano Di Chiara   +8 more
wiley   +1 more source

Impact of pimavanserin on prescribing practices in parkinson disease. [PDF]

Clin Park Relat Disord
Pham Nguyen TP, Le V, Weintraub D, Willis AW.   +3 more
europepmc   +1 more source

14-3-3 Proteins in Lewy Bodies in Parkinson Disease and Diffuse Lewy Body Disease Brains [PDF]

, 2002
Yasuhiro Kawamoto, Ichiro Akiguchi, Shinichi Nakamura, Yasuyuki Honjyo, Hiroshi Shibasaki, Herbert Budka   +5 more
openalex   +1 more source

Micro‐Coil Neuromodulation at Single‐Cell and Circuit Levels for Inhibiting Natural Neuroactivity, Neutralizing Electric Neural Excitation, and Suppressing Seizures

Advanced Science, EarlyView.
Micromagnetic stimulation (µMS) offers a precise method for neural inhibition, complementing existing neuromodulation techniques. Using an implantable micro‐coil device, µMS selectively suppresses cortical activity with high spatial resolution. It effectively counteracts micro‐electrode stimulation and reduces seizure amplitude, highlighting its ...
Kayeon Kim, Xiyuan Liu, Bingdong Chang, Guanghui Li, Gwendoline A. E. Anand, Su Genelioglu, Alexandra Katherine Isis Yonza, Andrew J Whalen, Rune W Berg, Shelley I Fried, Anpan Han, Changsi Cai   +11 more
wiley   +1 more source

Device-assisted therapies for Parkinson disease. [PDF]

Aust Prescr
Mouchaileh N, Cameron J.
europepmc   +1 more source